InnoUp Farma, SL
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
InnoUp Farma, SL - overview
Established
2015
Location
-, Navarra, Spain
Primary Industry
Pharmaceuticals
About
Founded in 2015 and based in Spain, InnoUp Farma, SL operates as a developer of nanotechnology that offers solutions for the administration of oral drugs. The company was founded by co-founders Manuel Rodríguez-Mariscal and Maite Agueros. In January 2021, InnoUp Farma, SL raised EUR 1 million in venture funding led by investor Centre for the Development of Industrial Technology, with participation from investors Inveready Asset Management and Sodena. The company operates as a clinical-stage company that offers oral drug delivery solutions such as peanut allergy vaccine and paclitaxel for the treatment of breast cancer that contain biocompatible nanoparticles with high bioadhesive capacity.
The company generated by developing oral drugs solution for cancer and peanut allergy. InnoUp Farma, SL plans to expand their company in 2021.
Current Investors
Inveready Asset Management, Sodena, Center for Technological & Industrial Development
Primary Industry
Pharmaceuticals
Sub Industries
Biotechnology, Oncology/Cancer Treatment, Pharmaceutical Research & Development
Website
www.innoupfarma.com/
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.